RSK1 is an exploitable dependency in myeloid malignancies [ATAC-seq]
RSK1 is an exploitable dependency in myeloid malignancies Overall design: THP-1 cells were treated with DMSO or 5 µM PMD-026 for 24h. ATAC-seq was performed.